120 Results

Braftovi triplet combination success in BEACON CRC trial in patients with BRAFV600E-mutant metastatic colorectal cancer

 Added 28 days ago

Array BioPharma Inc. announced positive results from the interim analysis of the Phase III BEACON CRC trial evaluating the combination...

Study of Signatera ctDNA assay in colorectal cancer published in JAMA Oncology

 Added 1 month ago

A new clinical study shows that Natera's Signatera ctDNA assay identified colorectal cancer recurrence up to 16.5 months earlier than...

Tecentriq and Cotellic combination fails Phase III trial to treat microsatellite-stable colorectal cancer

 Added 1 month ago

Tecentriq and Cotellic combination failed to improve survival over standard third-line therapy for patients with chemorefractory metastatic colorectal cancer (CRC)...

European Commission approves Zirabev (bevacizumab biosimilar) to treat the same indications as the originator product. Avastin. - Pfizer

 Added 3 months ago

Pfizer Inc. announced the European Commission (EC) has approved Zirabev for the treatment of metastatic carcinoma of the colon or...

Updated results from Phase III BEACON CRC trial evaluating Braftovi + Mektovi + Erbitux for BRAFV600E-mutant colorectal cancer.- Array Biopharma

 Added 5 months ago

Array Biopharma announced updated safety and efficacy results, including mature overall survival (OS), from the safety lead-in of the Phase...

Unravelling the microbiome – health through happy communities

 Added 2 months ago

Unravelling the microbiome – health through happy communities

The human body is host to trillions of microbial organisms which live on skin, for instance, on the surface of lungs and on the surface of the gut.

Chinese regulatory approval for Elunate to treat colorectal cancer.- Hutchison China MediTech .

 Added 9 months ago

Hutchison China MediTech Limited (“Chi-Med”) announces that fruquintinib capsules have been granted approval for drug registration by the National Medical...

Exact Sciences and Pfizer enter Into U.S. promotion agreement For Cologuard to diagnose colorectal cancer.

 Added 9 months ago

Exact Sciences Corp. and Pfizer Inc. announced an agreement through 2021 to co-promote Cologuard, the first and only FDA-approved non-invasive...

Updated results from BEACON CRC trial of Braftovi + Mektovi + cetuximab for patients with BRAFV600E-mutant metastatic colorectal cancer.-Array Biopharma.

 Added 10 months ago

As presented at the ESMO 20th World Congress on Gastrointestinal Cancer in June 2018 , the results from the safety...

Phase III MORA trial of Plenvu in bowel preparation published in Endoscopy.- Norgine.

 Added 10 months ago

Norgine announced that results from the Plenvu (polyethylene glycol based bowel preparation) Phase III MORA trial were published in ENDOSCOPY,...

Load more